OpenLobby.EU
Explore

Ordem dos Farmacêuticos

OF

A Ordem dos Farmacêuticos é a associação pública profissional representativa dos que exercem a profissão de farmacêutico em Portugal em defesa da garantia da assistência farmacêutica à população em território português São atribuições da Ordem: colaborar na definição e execução da política de saúde em cooperação com o Estado; defender a dignidade da profissão farmacêutica; fomentar e defender os interesses da assistência farmacêutica à população e da profissão de farmacêutico. Para prossecução das atribuições referidas a Ordem exerce a sua ação nos domínios social, científico, cultural, deontológico, profissional e económico da atividade farmacêutica. -Elabora estudos, emite pareceres e propõe soluções em matéria de política de saúde; -Coadjuva o Estado em ações que visem o acesso dos cidadãos aos cuidados médicos e farmacêuticos, medicamentosos, preventivos, curativos e de reabilitação, bem como nas de disciplina e controlo de produção e uso dos produtos químicos, b (...)

Lobbying Activity

Response to EU-Africa Global Health Partnership

27 Aug 2019

We welcome the proposal from the Commission for an EU-Africa Global Health Partnership, and we stress the importance of such initiative. As an organisation with 20+ years of strategic development in Portuguese Speaking African Countries in the healthcare sector, we acknowledge the need to finance projects and partnerships, allowing for a sustainable development on EU-Africa bridge. The Inception impact assessment is clear, and the roadmap is comprehensive regarding context, aims, policy identification and expected results. The burden of not only Infectious Diseases – but also other neglected diseases resulting from a globalized and fast-moving 21st century – calls for a faster development and safer use of health innovations for European patients and global health. The roadmap particularly focuses its aim on tackling the Sustainable Development Goal number 3 – Good Health and Wellbeing. Although slightly referred, it would be a bonus to reflect the thoughts on the migration movements that often contribute to the spread of infectious diseases, and the globalization of care, extending from Europe to other continents. A research program that includes as its strategic goals to empower governments, institutions and citizens in a strategic and sustainable fashion is the laying foundation for well-balanced financing partnerships. Given the burden of these diseases, partnerships should be focus on the development of vaccines, preventative measures and treatment of emergent diseases, and non-communicable diseases in middle-to-low-income countries. Whilst HIV-Aids, malaria and tuberculosis are highly ranked as diseases who can lead to an early death, non-communicable diseases are rapidly and silently becoming conditions with severe impact globally. Fragmentation of research (despite the existing funds) is often due to poor capacity building in developing countries. Therefore, it could be an option that a separate financing line is dedicated solely to researcher’s education, training and capacity building, consequently incrementing chances to have local institutions performing research, stimulating innovation and awarding best practices in a competitive environment, that thrives on excellency. In order to overcome fragmentation of research, the development of research consortiums with countries with similar interests should be further explored. This is particularly relevant for countries who share the same language and are better equipped to support each other on biomedical research and innovation for healthcare, including programs for exchange and mobility. Coordination among countries who share relevant overarching principles ease the process of international awareness. Partnership between countries that have common bridges (such as language, diseases, societal problems and inequalities, religion) could be an added value for partnership-building resolution. There has been less focus in Lusophone and Francophone countries in terms of information on healthcare. The fact that the language networks are responsible for an increase in relationships between countries, this asset should be further explored. Research centres, universities and public institutions are therefore in optimal places to unveil and operationalise a common strategy, supported by public funds, where appropriate with the intervention and support of the private sector. We agree with the roadmap and understand as the most relevant the Option 4: Institutionalised Partnership under Article 187 of the EU Treaty.
Read full response